Old Mutual Global Investors UK Ltd. raised its stake in shares of Orthofix International N.V. (NASDAQ:OFIX) by 250.3% during the third quarter, according to its most recent filing with the SEC. The fund owned 9,885 shares of the medical device company’s stock after buying an additional 7,063 shares during the period. Old Mutual Global Investors UK Ltd. owned about 0.05% of Orthofix International N.V. worth $422,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in OFIX. Swiss National Bank boosted its position in Orthofix International N.V. by 2.2% in the second quarter. Swiss National Bank now owns 32,900 shares of the medical device company’s stock valued at $1,395,000 after buying an additional 700 shares during the period. Emerald Acquisition Ltd. acquired a new position in Orthofix International N.V. during the second quarter valued at $4,435,000. First Trust Advisors LP acquired a new position in Orthofix International N.V. during the second quarter valued at $1,365,000. Lebenthal Lisanti Capital Growth LLC boosted its position in Orthofix International N.V. by 123.4% in the second quarter. Lebenthal Lisanti Capital Growth LLC now owns 21,830 shares of the medical device company’s stock valued at $926,000 after buying an additional 12,060 shares during the period. Finally, UBS Asset Management Americas Inc. boosted its position in Orthofix International N.V. by 15.4% in the second quarter. UBS Asset Management Americas Inc. now owns 10,511 shares of the medical device company’s stock valued at $446,000 after buying an additional 1,400 shares during the period. Institutional investors and hedge funds own 94.24% of the company’s stock.

Institutional Ownership by Quarter for Orthofix International N.V. (NASDAQ:OFIX)

Orthofix International N.V. (NASDAQ:OFIX) traded up 1.06% during midday trading on Friday, reaching $37.01. The company’s stock had a trading volume of 120,498 shares. Orthofix International N.V. has a 52-week low of $32.51 and a 52-week high of $48.25. The firm has a 50 day moving average of $36.99 and a 200 day moving average of $41.26. The firm has a market cap of $659.74 million, a P/E ratio of 70.76 and a beta of 0.44.

Orthofix International N.V. (NASDAQ:OFIX) last posted its earnings results on Monday, October 31st. The medical device company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.34 by $0.02. The firm earned $98.50 million during the quarter, compared to the consensus estimate of $103.40 million. Orthofix International N.V. had a return on equity of 9.01% and a net margin of 2.41%. The business’s quarterly revenue was down 2.7% on a year-over-year basis. During the same period last year, the company earned $0.30 earnings per share. Analysts anticipate that Orthofix International N.V. will post $1.42 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This story was originally posted by Daily Political and is the sole property of of Daily Political. If you are reading this story on another site, it was stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this story can be read at http://www.dailypolitical.com/2017/01/13/orthofix-international-n-v-ofix-position-raised-by-old-mutual-global-investors-uk-ltd.html.

Separately, Zacks Investment Research cut Orthofix International N.V. from a “buy” rating to a “hold” rating in a report on Tuesday, October 4th.

In other Orthofix International N.V. news, CEO Brad Mason sold 9,538 shares of the stock in a transaction dated Thursday, November 10th. The stock was sold at an average price of $36.83, for a total value of $351,284.54. Following the completion of the transaction, the chief executive officer now directly owns 151,219 shares in the company, valued at $5,569,395.77. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 5.10% of the stock is owned by company insiders.

About Orthofix International N.V.

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

5 Day Chart for NASDAQ:OFIX

Want to see what other hedge funds are holding OFIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Orthofix International N.V. (NASDAQ:OFIX).

Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with MarketBeat.com's FREE daily email newsletter.